Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKDC | P78527 | 7/20 | 0.48 |
| ▸ | GRM5 | P41594 | 1/20 | 0.38 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.38 |
| ▸ | TDO2 | P48775 | 1/20 | 0.38 |
| ▸ | GABRG2 | P18507 | 3/20 | 0.38 |
| ▸ | GABRB3 | P28472 | 3/20 | 0.38 |
| ▸ | GABRA5 | P31644 | 3/20 | 0.38 |
| ▸ | GABRA3 | P34903 | 3/20 | 0.38 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.38 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.37 |
| ▸ | MYC | P01106 | 1/20 | 0.37 |
| ▸ | PIM1 | P11309 | 1/20 | 0.36 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.35 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.35 |
| ▸ | ABCG2 | Q9UNQ0 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25066876 | 0.86 | PIM1 (0.39) | PRKDCGRM5TGFBR1TDO2GABRG2 | |
| SCHEMBL22316499 | 0.86 | GRM5 (0.43) | GRM5ABCG2 | |
| SCHEMBL25880719 | 0.84 | GRM5 (0.37) | GRM5TGFBR1TDO2CLK4PIM1 | |
| SCHEMBL26408767 | 0.84 | IDO1 (0.42) | PRKDCGRM5CLK4KDM4C | |
| SCHEMBL22316447 | 0.81 | PRKDC (0.51) | PRKDCTGFBR1GABRG2GABRB3GABRA5 | |
| SCHEMBL25880741 | 0.81 | GRM5 (0.35) | PRKDCGRM5TGFBR1PIM1 | |
| SCHEMBL25066860 | 0.80 | LPL (0.36) | PRKDCTGFBR1MYC | |
| SCHEMBL25636984 | 0.78 | PRKDC (0.55) | PRKDCGABRG2GABRB3GABRA5GABRA3 | |
| SCHEMBL22316452 | 0.77 | KDM4E (0.41) | TDO2PIM1ALOX5 | |
| SCHEMBL25880791 | 0.77 | ELANE (0.35) | PRKDCGRM5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11785839-B2 | Organic light-emitting materials containing cyano-substituted ligand | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2023-10-10 | — | — | US | disclosed |
| US-20200251666-A1 | ORGANIC LIGHT-EMITTING MATERIALS CONTAINING CYANO-SUBSTITUTED LIGAND | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2020-08-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200251666-A1 | ORGANIC LIGHT-EMITTING MATERIALS CONTAINING CYANO-SUBSTITUTED LIGAND | L1CAM, CYBA, ICOSLG | PRKDC 4619/4885GRM5 1109/4885TGFBR1 2658/4885 |
| US-11785839-B2 | Organic light-emitting materials containing cyano-substituted ligand | L1CAM, CYBA, ICOSLG | PRKDC 4619/4885GRM5 1109/4885TGFBR1 2658/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.